The PDGF B-chain is involved in the ontogenic susceptibility of the developing rat brain to NMDA toxicity

Experimental Neurology

Volumn 186, Issue 1, 2004, Pages 89-98

  Egawa Tsuzuki, Tomoko ^a   Ohno, Masaki ^a   Tanaka, Naoto ^a   Takeuchi, Yoshihiro ^a   Uramoto, Hidetaka ^b   Faigle, Roland ^b   Funa, Keiko ^b   Ishii, Yoko ^c   Sasahara, Masakiyo ^c  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Antisense oligonucleotides; Brain; Development; Excitotoxicity; Glutamate; Hypoxia; Immaturity; Ischemia; NMDA; Platelet derived growth factor

Indexed keywords

COMPLEMENTARY DNA; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLATELET DERIVED GROWTH FACTOR B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN TOXICITY; CELL MEMBRANE; CELL PROTECTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; EVOKED RESPONSE; NERVE CELL; NEUROPATHOLOGY; NEWBORN; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 1242338955     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2003.11.001     Document Type: Article

References (56)

1. Barkovich A.J. MR and CT evaluation of profound neonatal and infantile asphyxia. Am. J. Neuroradiol. 13:1992;959-972. (discussion 973-975).
2. Beck T., Lindholm D., Castren E., Wree A. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J. Cereb. Blood Flow Metab. 14:1994;689-692.
3. Bergsten E., Uutela M., Li X., Pietras K., Ostman A., Heldin C.H., Alitalo K., Eriksson U. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat. Cell Biol. 3:2001;512-516.
4. Bethel A., Kirsch J.R., Koehler R.C., Finklestein S.P., Traystman R.J. Intravenous basic fibroblast growth factor decreases brain injury resulting from focal ischemia in cats. Stroke. 28:1997;609-615. (discussion 615-616).
5. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
6. Boiziau C., Kurfurst R., Cazenave C., Roig V., Thuong N.T., Toulme J.J. Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism. Nucleic Acids Res. 19:1991;1113-1119.
7. Cheng Y., Gidday J.M., Yan Q., Shah A.R., Holtzman D.M. Marked age-dependent neuroprotection by brain-derived neurotrophic factor neonatal hypoxic-ischemic brain injury. Ann. Neurol. 41:1997;521-529.
8. Choi D.W., Koh J.Y., Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci. 8:1988;185-196.
9. Constantine-Paton M., Cline H.T., Debski E. Patterned activity, synaptic convergence, and the NMDA receptor in developing visual pathways. Annu. Rev. Neurosci. 13:1990;129-154.
10. Fisher M., Meadows M.E., Do T., Weise J., Trubetskoy V., Charette M., Finklestein S.P. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 15:1995;953-959.
11. Funa K., Ahgren A. Characterization of platelet-derived growth factor (PDGF) action on a mouse neuroblastoma cell line, NB41, by introduction of an antisense PDGF beta-receptor RNA. Cell Growth Differ. 8:1997;861-869.
12. Gilbertson D.G., Duff M.E., West J.W., Kelly J.D., Sheppard P.O., Hofstrand P.D., Gao Z., Shoemaker K., Bukowski T.R., Moore M., Feldhaus A.L., Humes J.M., Palmer T.E., Hart C.E. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J. Biol. Chem. 276:2001;27406-27414.
13. Gozal D., Simakajornboon N., Czapla M.A., Xue Y.D., Gozal E., Vlasic V., Lasky J.A., Liu J.Y. Brainstem activation of platelet-derived growth factor-beta receptor modulates the late phase of the hypoxic ventilatory response. Neurochemistry. 74:2000;310-319.
14. Hauptman M., Nelson D., Wilson D.F., Erecinska M. Neurotransmitter amino acids in the CNS: II. Some changes in amino acid levels in rat brain synaptosomes during and after in vitro anoxia and simulated ischemia. Brain Res. 304:1984;23-35.
15. Heldin C.H., Westermark B. Platelet-derived growth factor: three isoforms and two receptor types. Trends Genet. 5:1989;108-111.
16. Heldin C.H., Bäckström G., Östman A., Hammacher A., Ronnstrand L., Rubin K., Nistér M., Westermark B. Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types. EMBO J. 7:1988;1387-1393.
17. Iihara K., Hashimoto N., Tsukahara T., Sakata M., Yanamoto H., Taniguchi T. Platelet-derived growth factor-BB, but not -AA, prevents delayed neuronal death after forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 17:1997;1097-1106.
18. Ikonomidou C., Mosinger J.L., Salles K.S., Labruyere J., Olney J.W. Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-D-aspartate neurotoxicity. J. Neurosci. 9:1989;2809-2818.
19. Jansen M., de Moor C.H., Sussenbach J.S., van den Brande J.L. Translational control of gene expression. Pediatr. Res. 37:1995;681-686.
20. Johnston M.V., Trescher W.H., Ishida A., Nakajima W. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr. Res. 49:2001;735-741.
21. Kaneko M., Sasahara M., Takayama S., Handa J., Hazama F. Expression of platelet-derived growth factor after transient forebrain ischemia in the gerbil hippocampus. Acta Neuropathol. (Berl.). 95:1998;471-478.
22. Kawabe T., Wen T.C., Matsuda S., Ishihara K., Otsuda H., Sakanaka M. Platelet-derived growth factor prevents ischemia-induced neuronal injuries in vivo. Neurosci. Res. 29:1997;335-343.
23. Lei S., Lu W.Y., Xiong Z.G., Orser B.A., Valenzuela C.F., MacDonald J.F. Platelet-derived growth factor receptor-induced feed-forward inhibition of excitatory transmission between hippocampal pyramidal neurons. J. Biol. Chem. 274:1999;30617-30623.
24. Lindahl P., Hellstrom M., Kalen M., Karlsson L., Pekny M., Pekna M., Soriano P., Betsholtz C. Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development. 125:1998;3313-3322.
25. Maller A.I., Hankins L.L., Yeakley J.W., Butler I.J. Rolandic-type cerebral palsy in children as a pattern of hypoxic-ischemic injury in the full-term neonate. J. Child Neurol. 13:1988;313-321.
26. Matsui T., Pierce J.H., Fleming T.P., Greenberger J.S., LaRochelle W.J., Ruggiero M., Aaronson S.A. Independent expression of human alpha or beta platelet-derived growth factor receptor cDNAs in a naive hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways. Proc. Natl. Acad. Sci. U. S. A. 86:1989;8314-8318.
27. McDonald J.W., Johnston M.V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. Rev. 15:1990;41-70.
28. McDonald J.W., Silverstein F.S., Johnston M.V. Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res. 459:1988;200-203.
29. McDonald J.W., Trescher W.H., Johnston M.V. The selective ionotropic-type quisqualate receptor agonist AMPA is a potent neurotoxin in immature rat brain. Brain Res. 526:1990;165-168.
30. McDonald J.W., Trescher W.H., Johnston M.V. Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development. Brain Res. 583:1992;54-70.
31. Mekada A., Sasahara M., Yamada E., Kani K., Hazama F. Platelet-derived growth factor B-chain expression in the rat retina and optic nerve: distribution and changes after transection of the optic nerve. Vis. Res. 38:1998;3031-3039.
32. Menkes J.H., Curran J. Clinical and MR correlates in children with extrapyramidal cerebral palsy. Am. J. Neuroradiol. 15:1994;451-457.
33. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 12:1994;529-540.
34. Ohno M., Sasahara M., Narumiya S., Tanaka N., Yamano T., Shimada M., Hazama F. Expression of platelet-derived growth factor B-chain and beta-receptor in hypoxic/ischemic encephalopathy of neonatal rats. Neuroscience. 90:1999;643-651.
35. Pasternak J.F., Gorey M.T. The syndrome of acute near-total intrauterine asphyxia in the term infant. Pediatr. Neurol. 18:1998;391-398.
36. Rose C.R., Waxman S.G., Ransom B.R. Effects of glucose deprivation, chemical hypoxia, and simulated ischemia on Na+ homeostasis in rat spinal cord astrocytes. J. Neurosci. 18:1998;3554-3562.
37. Ross R., Raines E.W., Bowen-Pope D.F. The biology of platelet-derived growth factor. Cell. 46:1986;155-169.
38. Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J. Neurosci. 4:1984;1884-1891.
39. Sakata M., Yamamoto H., Hashimoto N., Iihara K., Tsukahara T., Taniguchi T., Kikuchi H. Induction of infarct tolerance by platelet-derived growth factor against temporary focal ischemia. Brain Res. 784:1998;250-255.
40. Sasahara A., Kott J.N., Sasahara M., Raines E.W., Ross R., Westrum L.E. Platelet-derived growth factor B-chain-like immunoreactivity in the developing and adult rat brain. Dev. Brain Res. 68:1992;41-53.
41. Sasahara M., Fries J.W.U., Raines E.W., Gown A.M., Westrum L.E., Frosch M.P., Bonthron D.T., Ross R., Collins T. PDGF-B chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell. 64:1991;217-227.
42. Sasahara M., Sato H., Iihara K., Wang J., Chue C.H., Takayama S., Hayase Y., Hazama F. Expression of platelet-derived growth factor B-chain in the mature rat brain and pituitary gland. Brain Res. Mol. Brain Res. 32:1995;63-74.
43. Sasahara M., Amano S., Sato H., Yang J.G., Hayase Y., Kaneko M., Sato I., Suzaki M., Hazama F. Normal developing rat brain expresses a platelet-derived growth factor B chain (c-sis) mRNA truncated at the 5′ end. Oncogene. 16:1998;1571-1578.
44. Schabitz W.R., Schwab S., Spranger M., Hacke W. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 17:1997;500-506.
45. Seifert R.A., Hart C.E., Phillips P.E., Forstrom J.W., Ross R., Murray M.J., Bowen-Pope D.F. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J. Biol. Chem. 264:1989;8771-8778.
46. Shigeno T., Mima T., Takakura K., Graham D.I., Kato G., Hashimoto Y., Furukawa S. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J. Neurosci. 11:1991;2914-2919.
47. Sims K.D., Straff D.J., Robinson M.B. Platelet-derived growth factor rapidly increases activity and cell surface expression of the EAAC1 subtype of glutamate transporter through activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 275:2000;5228-5237.
48. Smits A., Kato M., Westermark B., Nister M., Heldin C-H., Funa K. Neurotrophic activity of platelet-derived growth factor (PDGF):rat neuronal cells possess functional PDGFβ-type receptor and respond to PDGF. Proc. Natl. Acad. Sci. U. S. A. 88:1991;8159-8163.
49. Stastny F., Lisy V., Tomasova H., Trojan S. Effects of short-term and prolonged aerogenic hypoxia on gamma-glutamyl transpeptidase activity in the brain, liver, and biological fluids of young rats. Neurochem. Res. 10:1985;819-828.
50. Sun L., Margolis F.L., Shipley M.T., Lidow M.S. Identification of a long variant of mRNA encoding the NR3 subunit of the NMDA receptor: its regional distribution and developmental expression in the rat brain. FEBS Lett. 441:1998;392-396.
51. Tallquist M.D., Soriano P. Cell autonomous requirement for PDGFRalpha in populations of cranial and cardiac neural crest cells. Development. 130:2003;507-518.
52. Tsien J.Z., Huerta P.T., Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell. 87:1996;1327-1338.
53. Valenzuela C.F., Xiong Z., MacDonald J.F., Weiner J.L., Fraizer C.J., Dunwiddle T.V., Kazlauska A., Whiting P.J., Harris R.A. Platelet-derived growth factor induces a long-term inhibition of N-methyl-D-aspartate receptor function. J. Biol. Chem. 271:1996;16151-16159.
54. Westmark K.D., Barkovich A.J., Sola A., Ferriero D., Partridge J.C. Patterns and implications of MR contrast enhancement in perinatal asphyxia: a preliminary report. Am. J. Neuroradiol. 16:1995;685-692.
55. Whitelaw A. Systematic review of therapy after hypoxic-ischaemic brain injury in the perinatal period. Semin. Neonatol. 5:2000;33-40.
56. Yamakura T., Shimoji K. Subunit- and site-specific pharmacology of the NMDA receptor channel. Prog. Neurobiol. 59:1999;279-298.